Regulation of NKG2D Stress Ligands and Its Relevance in Cancer Progression
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Regulation of NKG2D Stress Ligands and Its Relevance in Cancer Progression
Authors
Keywords
-
Journal
Cancers
Volume 14, Issue 9, Pages 2339
Publisher
MDPI AG
Online
2022-05-10
DOI
10.3390/cancers14092339
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- In vivo efficacy of decitabine as a natural killer cell–mediated immunotherapy against isocitrate dehydrogenase mutant gliomas
- (2022) Xiaoran Zhang et al. Neurosurgical Focus
- Immune ULBP1 is Elevated in Colon Adenocarcinoma and Predicts Prognosis
- (2022) Guo-Tian Ruan et al. Frontiers in Genetics
- Natural killer cells efficiently target multiple myeloma clonogenic tumor cells
- (2021) Alejandra Leivas et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Tumor hypoxia represses γδ T cell-mediated antitumor immunity against brain tumors
- (2021) Jang Hyun Park et al. NATURE IMMUNOLOGY
- Heat‐killed Helicobacter pylori upregulates NKG2D ligands expression on gastric adenocarcinoma cells via Toll‐like receptor 4
- (2021) Carolina Hernández et al. HELICOBACTER
- Small-molecule HDAC and Akt inhibitors suppress tumor growth and enhance immunotherapy in multiple myeloma
- (2021) Mitsuhito Hirano et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Oncolytic HSV-1 G207 Immunovirotherapy for Pediatric High-Grade Gliomas
- (2021) Gregory K. Friedman et al. NEW ENGLAND JOURNAL OF MEDICINE
- An inhibitor of programmed death ligand 1 enhances natural killer cell-mediated immunity against malignant melanoma cells
- (2021) Young Shin Lee et al. PLoS One
- Role of Polymorphisms of NKG2D Receptor and Its Ligands in Acute Myeloid Leukemia and Human Stem Cell Transplantation
- (2021) Alena Machuldova et al. Frontiers in Immunology
- Downregulation of NKG2DLs by TGF-β in human lung cancer cells
- (2021) Young Shin Lee et al. BMC IMMUNOLOGY
- Histone‐deacetylase 8 drives the immune response and the growth of glioma
- (2021) Alessandro Mormino et al. GLIA
- A combined treatment regimen of MGMT-modified γδ T cells and temozolomide chemotherapy is effective against primary high grade gliomas
- (2021) Lawrence S. Lamb et al. Scientific Reports
- ATM kinase regulates tumor immunoreactions in lymphocyte-predominant breast cancer through modulation of NKG2D ligand and TNF cytokines on tumor cells
- (2020) Peng Xu et al. Medical Molecular Morphology
- Epithelial‐mesenchymal transition may be involved in the immune evasion of circulating gastric tumor cells via downregulation of ULBP1
- (2020) Baoguang Hu et al. Cancer Medicine
- Low-Dose Gemcitabine Treatment Enhances Immunogenicity and Natural Killer Cell-Driven Tumor Immunity in Lung Cancer
- (2020) Xin Zhang et al. Frontiers in Immunology
- Glycolysis and Oxidative Phosphorylation Play Critical Roles in Natural Killer Cell Receptor-Mediated Natural Killer Cell Functions
- (2020) Zixi Wang et al. Frontiers in Immunology
- Pemetrexed sensitizes human lung cancer cells to cytotoxic immune cells
- (2020) Tamio Okimoto et al. CANCER SCIENCE
- A Disintegrin and Metalloproteinase 9 (ADAM9) in Advanced Hepatocellular Carcinoma and Their Role as a Biomarker During Hepatocellular Carcinoma Immunotherapy
- (2020) Sooyeon Oh et al. Cancers
- Boosting Natural Killer Cell-Based Cancer Immunotherapy with Selenocystine/Transforming Growth Factor-Beta Inhibitor-Encapsulated Nanoemulsion
- (2020) Chang Liu et al. ACS Nano
- Oxidative Stress in Cancer
- (2020) John D. Hayes et al. CANCER CELL
- Hypoxia Impairs NK Cell Cytotoxicity through SHP-1-Mediated Attenuation of STAT3 and ERK Signaling Pathways
- (2020) Rui Teng et al. Journal of Immunology Research
- Cytoplasmic Citrate Flux Modulates the Immune Stimulatory NKG2D Ligand MICA in Cancer Cells
- (2020) Sofie H. Møller et al. Frontiers in Immunology
- ULBP1 Is Elevated in Human Hepatocellular Carcinoma and Predicts Outcome
- (2020) Nicholas J. W. Easom et al. Frontiers in Oncology
- Metabolism of short‐chain fatty acid propionate induces surface expression of NKG2D ligands on cancer cells
- (2020) Rikke Illum Høgh et al. FASEB JOURNAL
- BRAF inhibitor resistance of melanoma cells triggers increased susceptibility to natural killer cell-mediated lysis
- (2020) Alexandra Frazao et al. Journal for ImmunoTherapy of Cancer
- Bortezomib enhances cytotoxicity of ex vivo-expanded gamma delta T cells against acute myeloid leukemia and T-cell acute lymphoblastic leukemia
- (2020) Jamie Y. Story et al. CYTOTHERAPY
- Immune evasion by TGFβ-induced miR-183 repression of MICA/B expression in human lung tumor cells
- (2019) Thu Le Trinh et al. OncoImmunology
- In vitro culture with gemcitabine augments death receptor and NKG2D ligand expression on tumour cells
- (2019) Andrew M. Gravett et al. Scientific Reports
- Natural killer group 2D receptor and its ligands in cancer immune escape
- (2019) Shixin Duan et al. Molecular Cancer
- Trabectedin triggers direct and NK-mediated cytotoxicity in multiple myeloma
- (2019) Maria Cucè et al. Journal of Hematology & Oncology
- Absence of NKG2D ligands defines leukaemia stem cells and mediates their immune evasion
- (2019) Anna M. Paczulla et al. NATURE
- Effect of platinum‑based chemotherapy on the expression of natural killer group�2 member�D ligands, programmed cell death‑1 ligand�1 and HLA class�I in non‑small cell lung cancer
- (2019) Riki Okita et al. ONCOLOGY REPORTS
- BCL11B regulates MICA/B-mediated immune response by acting as a competitive endogenous RNA
- (2019) Mengyao Qian et al. ONCOGENE
- Inhibition of Asparagine-linked Glycosylation Participates in Hypoxia-induced Down-regulation of Cell-surface MICA Expression
- (2018) ANTICANCER RESEARCH
- NKG2D ligands in glioma stem-like cells: expression in situ and in vitro
- (2018) Charlotte Flüh et al. HISTOCHEMISTRY AND CELL BIOLOGY
- The Immune Landscape of Cancer
- (2018) Vésteinn Thorsson et al. IMMUNITY
- Cancer-Cell-Intrinsic Mechanisms Shaping the Tumor Immune Landscape
- (2018) Max D. Wellenstein et al. IMMUNITY
- The cGAS–cGAMP–STING pathway connects DNA damage to inflammation, senescence, and cancer
- (2018) Tuo Li et al. JOURNAL OF EXPERIMENTAL MEDICINE
- The combination of ionizing radiation and proteasomal inhibition by bortezomib enhances the expression of NKG2D ligands in multiple myeloma cells
- (2018) Young Shin Lee et al. JOURNAL OF RADIATION RESEARCH
- Combined inhibition of JAK1,2/Stat3‑PD‑L1 signaling pathway suppresses the immune escape of castration‑resistant prostate cancer to NK cells in hypoxia
- (2018) Li‑Jun Xu et al. Molecular Medicine Reports
- Inhibition of IL-6-JAK/Stat3 signaling in castration-resistant prostate cancer cells enhances the NK cell-mediated cytotoxicity via alteration of PD-L1/NKG2D ligand levels
- (2018) LiJun Xu et al. Molecular Oncology
- Decitabine Enhances Vγ9Vδ2 T Cell-Mediated Cytotoxic Effects on Osteosarcoma Cells via the NKG2DL–NKG2D Axis
- (2018) Zhan Wang et al. Frontiers in Immunology
- The Role of Natural Killer Group 2, Member D in Chronic Inflammation and Autoimmunity
- (2018) Marina Babic et al. Frontiers in Immunology
- NKG2D and Its Ligands: “One for All, All for One”
- (2018) Alessandra Zingoni et al. Frontiers in Immunology
- More than Decoration: Roles for Natural Killer Group 2 Member D Ligand Expression by Immune Cells
- (2018) Andrew P. Trembath et al. Frontiers in Immunology
- NKG2D: A Master Regulator of Immune Cell Responsiveness
- (2018) Felix M. Wensveen et al. Frontiers in Immunology
- Functional Plasticity of Gamma Delta T Cells and Breast Tumor Targets in Hypoxia
- (2018) Gabrielle M. Siegers et al. Frontiers in Immunology
- The advent of oncolytic virotherapy in oncology: The Rigvir® story
- (2018) Pēteris Alberts et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- A Paradigm Shift in Cancer Immunotherapy: From Enhancement to Normalization
- (2018) Miguel F. Sanmamed et al. CELL
- Roles of the immune system in cancer: from tumor initiation to metastatic progression
- (2018) Hugo Gonzalez et al. GENES & DEVELOPMENT
- MG132 selectively upregulates MICB through the DNA damage response pathway in A549 cells
- (2018) Dan Luo et al. Molecular Medicine Reports
- Survival Mechanisms and Influence Factors of Circulating Tumor Cells
- (2018) Wen-Chao Wang et al. Biomed Research International
- Intestinal epithelial cell endoplasmic reticulum stress promotes MULT1 up-regulation and NKG2D-mediated inflammation
- (2017) Shuhei Hosomi et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Sunitinib Induces NK-κB-dependent NKG2D Ligand Expression in Nasopharyngeal Carcinoma and Hepatoma Cells
- (2017) Yu-xian Huang et al. JOURNAL OF IMMUNOTHERAPY
- Radiation alters PD-L1/NKG2D ligand levels in lung cancer cells and leads to immune escape from NK cell cytotoxicity via IL-6-MEK/Erk signaling pathway
- (2017) Ming Jing Shen et al. Oncotarget
- How Mucosal Epithelia Deal with Stress: Role of NKG2D/NKG2D Ligands during Inflammation
- (2017) Fabrizio Antonangeli et al. Frontiers in Immunology
- Control of Tumor Initiation by NKG2D Naturally Expressed on Ovarian Cancer Cells
- (2017) Xin Cai et al. NEOPLASIA
- Impaired NK cell recognition of vemurafenib-treated melanoma cells is overcome by simultaneous application of histone deacetylase inhibitors
- (2017) Sheila López-Cobo et al. OncoImmunology
- MHC class I chain-related molecule A and B expression is upregulated by cisplatin and associated with good prognosis in patients with non-small cell lung cancer
- (2016) Riki Okita et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- TGFβR1 Blockade with Galunisertib (LY2157299) Enhances Anti-Neuroblastoma Activity of the Anti-GD2 Antibody Dinutuximab (ch14.18) with Natural Killer Cells
- (2016) Hung C. Tran et al. CLINICAL CANCER RESEARCH
- Initiation of innate immune responses by surveillance of homeostasis perturbations
- (2016) Henrique G. Colaço et al. FEBS Journal
- The Immune System in Tissue Environments Regaining Homeostasis after Injury: Is “Inflammation” Always Inflammation?
- (2016) Onkar P. Kulkarni et al. MEDIATORS OF INFLAMMATION
- Cancer stem cells
- (2016) Jenny C. Chang MEDICINE
- IDH mutant gliomas escape natural killer cell immune surveillance by downregulation of NKG2D ligand expression
- (2016) Xiaoran Zhang et al. NEURO-ONCOLOGY
- Regulation of NKG2D Expression and Signaling by Endocytosis
- (2016) Rosa Molfetta et al. TRENDS IN IMMUNOLOGY
- Low-dose bortezomib increases the expression of NKG2D and DNAM-1 ligands and enhances induced NK and γδ T cell-mediated lysis in multiple myeloma
- (2016) Chao Niu et al. Oncotarget
- The concept of immune surveillance against tumors: The first theories
- (2016) Domenico Ribatti Oncotarget
- The safety of allogeneic innate lymphocyte therapy for glioma patients with prior cranial irradiation
- (2015) Larisa Pereboeva et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Erlotinib enhances the CIK cell-killing sensitivity of lung adenocarcinoma A549 cells
- (2015) J.Z. Mei et al. GENETICS AND MOLECULAR RESEARCH
- Tumor Therapeutics Work as Stress Inducers to Enhance Tumor Sensitivity to Natural Killer (NK) Cell Cytolysis by Up-regulating NKp30 Ligand B7-H6
- (2015) Guoshuai Cao et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Genotoxic Stress Induces Senescence-Associated ADAM10-Dependent Release of NKG2D MIC Ligands in Multiple Myeloma Cells
- (2015) Alessandra Zingoni et al. JOURNAL OF IMMUNOLOGY
- Sulforaphane induces ROS mediated induction of NKG2D ligands in human cancer cell lines and enhances susceptibility to NK cell mediated lysis
- (2015) Prayag J. Amin et al. LIFE SCIENCES
- Contrasting Effects of the Cytotoxic Anticancer Drug Gemcitabine and the EGFR Tyrosine Kinase Inhibitor Gefitinib on NK Cell-Mediated Cytotoxicity via Regulation of NKG2D Ligand in Non-Small-Cell Lung Cancer Cells
- (2015) Riki Okita et al. PLoS One
- Sustained proliferation in cancer: Mechanisms and novel therapeutic targets
- (2015) Mark A. Feitelson et al. SEMINARS IN CANCER BIOLOGY
- Immune evasion in cancer: Mechanistic basis and therapeutic strategies
- (2015) Dass S. Vinay et al. SEMINARS IN CANCER BIOLOGY
- Differential expression of ligands for NKG2D and DNAM-1 receptors by epithelial ovarian cancer-derived exosomes and its influence on NK cell cytotoxicity
- (2015) Alireza Labani-Motlagh et al. TUMOR BIOLOGY
- The NKG2D – IL-15 signaling pathway contributes to T-cell mediated pathology in inflammatory myopathies
- (2015) Tobias Ruck et al. Oncotarget
- NKG2D Receptor and Its Ligands in Host Defense
- (2015) L. L. Lanier Cancer Immunology Research
- NKG2D- and T-cell receptor-dependent lysis of malignant glioma cell lines by human γδ T cells: Modulation by temozolomide and A disintegrin and metalloproteases 10 and 17 inhibitors
- (2015) Guranda Chitadze et al. OncoImmunology
- Drug-induced hyperploidy stimulates an antitumor NK cell response mediated by NKG2D and DNAM-1 receptors
- (2015) Andrea Acebes-Huerta et al. OncoImmunology
- Hypoxic tumor-derived microvesicles negatively regulate NK cell function by a mechanism involving TGF-β and miR23a transfer
- (2015) Guy Berchem et al. OncoImmunology
- MICA/B and ULBP1 NKG2D ligands are independent predictors of good prognosis in cervical cancer
- (2015) Hanbyoul Cho et al. BMC CANCER
- 5-Fluorouracil and Interleukin-2 Immunochemotherapy Enhances Immunogenicity of Non-Small Cell Lung Cancer A549 Cells through Upregulation of NKG2D Ligands
- (2014) Lei Zhao et al. Asian Pacific Journal of Cancer Prevention
- Immune Escape and Survival Mechanisms in Circulating Tumor Cells of Colorectal Cancer
- (2014) Gunnar Steinert et al. CANCER RESEARCH
- RAE1 Ligands for the NKG2D Receptor Are Regulated by STING-Dependent DNA Sensor Pathways in Lymphoma
- (2014) Adeline R. Lam et al. CANCER RESEARCH
- MICA polymorphism: biology and importance in cancer
- (2014) D. Chen et al. CARCINOGENESIS
- NKG2D signaling in cancer immunosurveillance
- (2014) Alejandro López-Soto et al. INTERNATIONAL JOURNAL OF CANCER
- MICA SNPs and the NKG2D system in virus-induced HCC
- (2014) Kaku Goto et al. JOURNAL OF GASTROENTEROLOGY
- Human Tumor-Derived Exosomes Down-Modulate NKG2D Expression
- (2014) A. Clayton et al. JOURNAL OF IMMUNOLOGY
- Cutting Edge: The Metalloproteinase ADAM17/TNF- -Converting Enzyme Regulates Proteolytic Shedding of the MHC Class I-Related Chain B Protein
- (2014) P. Boutet et al. JOURNAL OF IMMUNOLOGY
- Prostate Tumor-Derived Exosomes Down-Regulate NKG2D Expression on Natural Killer Cells and CD8+ T Cells: Mechanism of Immune Evasion
- (2014) Marie Lundholm et al. PLoS One
- Role of NKG2D in Obesity-Induced Adipose Tissue Inflammation and Insulin Resistance
- (2014) Jun-Jae Chung et al. PLoS One
- Synergistic enhancement of NK cell-mediated cytotoxicity by combination of histone deacetylase inhibitor and ionizing radiation
- (2014) Cheol-Hun Son et al. Radiation Oncology
- The DNA Damage Response: A Common Pathway in the Regulation of NKG2D and DNAM-1 Ligand Expression in Normal, Infected, and Cancer Cells
- (2014) Cristina Cerboni et al. Frontiers in Immunology
- Regulation of Ligands for the NKG2D Activating Receptor
- (2013) David H. Raulet et al. Annual Review of Immunology
- Immune modulation of T-cell and NK (natural killer) cell activities by TEXs (tumour-derived exosomes)
- (2013) Theresa L. Whiteside BIOCHEMICAL SOCIETY TRANSACTIONS
- Induction of the DNA damage response by IAP inhibition triggers natural immunity via upregulation of NKG2D ligands in Hodgkin lymphoma in vitro
- (2013) Maike Sauer et al. BIOLOGICAL CHEMISTRY
- Ataxia-telangiectasia mutated kinase-mediated upregulation of NKG2D ligands on leukemia cells by resveratrol results in enhanced natural killer cell susceptibility
- (2013) J. Luis Espinoza et al. CANCER SCIENCE
- Immune-based mechanisms of cytotoxic chemotherapy: implications for the design of novel and rationale-based combined treatments against cancer
- (2013) L Bracci et al. CELL DEATH AND DIFFERENTIATION
- Hypoxia downregulates the expression of activating receptors involved in NK-cell-mediated target cell killing without affecting ADCC
- (2013) Mirna Balsamo et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- Enhanced interaction between natural killer cells and lung cancer cells: involvement in gefitinib-mediated immunoregulation
- (2013) Sisi He et al. Journal of Translational Medicine
- Engineered Drug Resistant γδ T Cells Kill Glioblastoma Cell Lines during a Chemotherapy Challenge: A Strategy for Combining Chemo- and Immunotherapy
- (2013) Lawrence S. Lamb et al. PLoS One
- Hypoxia Induced Impairment of NK Cell Cytotoxicity against Multiple Myeloma Can Be Overcome by IL-2 Activation of the NK Cells
- (2013) Subhashis Sarkar et al. PLoS One
- Dacarbazine mediates antimelanoma effects via NK cells
- (2013) Alice Hervieu et al. OncoImmunology
- New prospects on the NKG2D/NKG2DL system for oncology
- (2013) Evelyn Ullrich et al. OncoImmunology
- The Effect of Chemotherapy/Radiotherapy on Cancerous Pattern Recognition by NK Cells
- (2012) B. Rosental et al. CURRENT MEDICINAL CHEMISTRY
- Prevalence of the NKG2D Thr72Ala Polymorphism in Patients with Cervical Carcinoma
- (2012) Andrzej Roszak et al. Genetic Testing and Molecular Biomarkers
- Tumorigenic adenovirus 12 cells evade NK cell lysis by reducing the expression of NKG2D ligands
- (2012) Christa Y. Heyward et al. IMMUNOLOGY LETTERS
- Hypoxia downregulates the expression of cell surface MICA without increasing soluble MICA in osteosarcoma cells in a HIF-1α-dependent manner
- (2012) NAOKO YAMADA et al. INTERNATIONAL JOURNAL OF ONCOLOGY
- Ectopically Expressed Human Tumor Biomarker MutS Homologue 2 Is a Novel Endogenous Ligand That Is Recognized by Human γδ T Cells to Induce Innate Anti-tumor/Virus Immunity
- (2012) Yumei Dai et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- RAE-1 ligands for the NKG2D receptor are regulated by E2F transcription factors, which control cell cycle entry
- (2012) Heiyoun Jung et al. JOURNAL OF EXPERIMENTAL MEDICINE
- HER2/HER3 Signaling Regulates NK Cell-Mediated Cytotoxicity via MHC Class I Chain-Related Molecule A and B Expression in Human Breast Cancer Cell Lines
- (2012) R. Okita et al. JOURNAL OF IMMUNOLOGY
- Involvement of an NKG2D Ligand H60c in Epidermal Dendritic T Cell-Mediated Wound Repair
- (2012) S. Yoshida et al. JOURNAL OF IMMUNOLOGY
- 2-Deoxy D-Glucose Prevents Cell Surface Expression of NKG2D Ligands through Inhibition of N-Linked Glycosylation
- (2012) L. Andresen et al. JOURNAL OF IMMUNOLOGY
- Comprehensive Analysis of NKG2D Ligand Expression and Release in Leukemia: Implications for NKG2D-Mediated NK Cell Responses
- (2012) J. Hilpert et al. JOURNAL OF IMMUNOLOGY
- Ras Activation Induces Expression of Raet1 Family NK Receptor Ligands
- (2012) X. V. Liu et al. JOURNAL OF IMMUNOLOGY
- 5-Fluorouracil and Interferon-α Immunochemotherapy Enhances Immunogenicity of Murine Pancreatic Cancer Through Upregulation of NKG2D Ligands and MHC Class I
- (2012) Hadeel Khallouf et al. JOURNAL OF IMMUNOTHERAPY
- Dacarbazine-Mediated Upregulation of NKG2D Ligands on Tumor Cells Activates NK and CD8 T Cells and Restrains Melanoma Growth
- (2012) Alice Hervieu et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- Tumor-Targeted Delivery of IL-2 by NKG2D Leads to Accumulation of Antigen-Specific CD8+ T Cells in the Tumor Loci and Enhanced Anti-Tumor Effects
- (2012) Tae Heung Kang et al. PLoS One
- The cooperating mutation or "second hit" determines the immunologic visibility toward MYC-induced murine lymphomas
- (2011) C. Schuster et al. BLOOD
- High ERp5/ADAM10 expression in lymph node microenvironment and impaired NKG2D ligands recognition in Hodgkin lymphomas
- (2011) M. R. Zocchi et al. BLOOD
- Human NK Cells Are Alerted to Induction of p53 in Cancer Cells by Upregulation of the NKG2D Ligands ULBP1 and ULBP2
- (2011) S. Textor et al. CANCER RESEARCH
- MMP9 mediates MICA shedding in human osteosarcomas
- (2011) Dahui Sun et al. CELL BIOLOGY INTERNATIONAL
- Regulation of immune cell function and differentiation by the NKG2D receptor
- (2011) Biljana Zafirova et al. CELLULAR AND MOLECULAR LIFE SCIENCES
- Prevalence of the NKG2D Thr72Ala polymorphism in patients with systemic lupus erythematosus
- (2011) Piotr Piotrowski et al. MOLECULAR BIOLOGY REPORTS
- TGF- downregulates the activating receptor NKG2D on NK cells and CD8+ T cells in glioma patients
- (2011) C. A. Crane et al. NEURO-ONCOLOGY
- Thermal- and Oxidative Stress Causes Enhanced Release of NKG2D Ligand-Bearing Immunosuppressive Exosomes in Leukemia/Lymphoma T and B Cells
- (2011) Malin Hedlund et al. PLoS One
- Expression of the RAE-1 Family of Stimulatory NK-Cell Ligands Requires Activation of the PI3K Pathway during Viral Infection and Transformation
- (2011) Maria Tokuyama et al. PLoS Pathogens
- Natural Killer Cell Cytotoxicity Is Suppressed by Exposure to the Human NKG2D Ligand MICA*008 That Is Shed by Tumor Cells in Exosomes
- (2010) O. Ashiru et al. CANCER RESEARCH
- Comparative genomic analysis of mammalian NKG2D ligand family genes provides insights into their origin and evolution
- (2010) Mizuho Kondo et al. IMMUNOGENETICS
- Role of sorafenib and sunitinib in the induction of expressions of NKG2D ligands in nasopharyngeal carcinoma with high expression of ABCG2
- (2010) Yuxian Huang et al. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
- Quercetin Enhances Susceptibility to NK Cell-mediated Lysis of Tumor Cells Through Induction of NKG2D Ligands and Suppression of HSP70
- (2010) Jae-Ho Bae et al. JOURNAL OF IMMUNOTHERAPY
- Association of NKG2D genetic polymorphism with susceptibility to chronic hepatitis B in a Han Chinese population
- (2010) Juan Ma et al. JOURNAL OF MEDICAL VIROLOGY
- Expression of heat shock protein 70 and NKG2D ligands in acute myeloid leukemia cell lines
- (2010) Ilona Hromadnikova et al. JOURNAL OF RECEPTORS AND SIGNAL TRANSDUCTION
- Complement: a key system for immune surveillance and homeostasis
- (2010) Daniel Ricklin et al. NATURE IMMUNOLOGY
- MICA polymorphism: biology and importance in immunity and disease
- (2010) Mun-Kit Choy et al. TRENDS IN MOLECULAR MEDICINE
- Anticancer Chemotherapy Inhibits MHC Class I-Related Chain A Ectodomain Shedding by Downregulating ADAM10 Expression in Hepatocellular Carcinoma
- (2009) K. Kohga et al. CANCER RESEARCH
- Heat Shock Protein 90 Inhibitor BIIB021 (CNF2024) Depletes NF- B and Sensitizes Hodgkin's Lymphoma Cells for Natural Killer Cell-Mediated Cytotoxicity
- (2009) B. Boll et al. CLINICAL CANCER RESEARCH
- Differential Clinical Significance of Individual NKG2D Ligands in Melanoma: Soluble ULBP2 as an Indicator of Poor Prognosis Superior to S100B
- (2009) A. Paschen et al. CLINICAL CANCER RESEARCH
- NKG2D Ligand Expression in Human Colorectal Cancer Reveals Associations with Prognosis and Evidence for Immunoediting
- (2009) R. W. McGilvray et al. CLINICAL CANCER RESEARCH
- ULBP6/RAET1L is an additional human NKG2D ligand
- (2009) Robert A. Eagle et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- Human acute myeloid leukemia CD34+CD38- stem cells are susceptible to allorecognition and lysis by single KIR-expressing natural killer cells
- (2009) U. Langenkamp et al. HAEMATOLOGICA
- The Traffic of the NKG2D/Dap10 Receptor Complex during Natural Killer (NK) Cell Activation
- (2009) Pedro Roda-Navarro et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Heat Shock Protein-90 Inhibitors Increase MHC Class I-Related Chain A and B Ligand Expression on Multiple Myeloma Cells and Their Ability to Trigger NK Cell Degranulation
- (2009) C. Fionda et al. JOURNAL OF IMMUNOLOGY
- Dendritic Cell-Derived Exosomes Promote Natural Killer Cell Activation and Proliferation: A Role for NKG2D Ligands and IL-15Rα
- (2009) Sophie Viaud et al. PLoS One
- Sustained NKG2D engagement induces cross-tolerance of multiple distinct NK cell activation pathways
- (2008) J. D. Coudert et al. BLOOD
- ATM-ATR-dependent up-regulation of DNAM-1 and NKG2D ligands on multiple myeloma cells by therapeutic agents results in enhanced NK-cell susceptibility and is associated with a senescent phenotype
- (2008) A. Soriani et al. BLOOD
- Hypoxia Increases Tumor Cell Shedding of MHC Class I Chain-Related Molecule: Role of Nitric Oxide
- (2008) D. R. Siemens et al. CANCER RESEARCH
- Opposing effects of interferon-α and interferon-γ on the expression of major histocompatibility complex class I chain-related A in tumors
- (2008) Cai Zhang et al. CANCER SCIENCE
- Interferon-γ down-regulates NKG2D ligand expression and impairs the NKG2D-mediated cytolysis of MHC class I-deficient melanoma by natural killer cells
- (2008) Nicole Schwinn et al. INTERNATIONAL JOURNAL OF CANCER
- Adenovirus E3/19K Promotes Evasion of NK Cell Recognition by Intracellular Sequestration of the NKG2D Ligands Major Histocompatibility Complex Class I Chain-Related Proteins A and B
- (2008) B. P. McSharry et al. JOURNAL OF VIROLOGY
- Acute upregulation of an NKG2D ligand promotes rapid reorganization of a local immune compartment with pleiotropic effects on carcinogenesis
- (2008) Jessica Strid et al. NATURE IMMUNOLOGY
- NKG2D ligands in tumor immunity
- (2008) N Nausch et al. ONCOGENE
- Intrinsic sensor of oncogenic transformation induces a signal for innate immunosurveillance
- (2008) A. M. Unni et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- The NKG2D receptor: sensing stressed cells
- (2008) Carlos López-Larrea et al. TRENDS IN MOLECULAR MEDICINE
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now